Venus Concept Inc. Joins Russell 2000®, Russell 3000® and Russell Microcap® Indexes
June 26 2020 - 7:30AM
Venus Concept Inc. (“Venus Concept” or the
“Company”) (NASDAQ: VERO), a global medical aesthetic
technology leader, announced today that the Company has been added
to the Russell 2000®, Russell 3000® and Russell Microcap® Indexes.
The Company’s inclusion in these indexes will become effective
today after the US market close.
Russell indexes are widely used by investment managers and
institutional investors for index funds and as benchmarks for
active investment strategies. Approximately $9 trillion in assets
are benchmarked against Russell’s US indexes.
“We are pleased to join these three Russell indexes,” said
Domenic Serafino, Chief Executive Officer and Director of Venus
Concept. “We continue to believe the long-term opportunity remains
extremely compelling for us as a leading player in both the global
minimally invasive/non-invasive medical aesthetics market and the
minimally invasive surgical hair restoration market.”
FTSE Russell determines membership for its Russell indexes
primarily by objective, market-capitalization rankings and style
attributes. Membership in the Russell 3000 Index, which remains in
place for one year, means automatic inclusion in either the
large-cap Russell 1000® Index or small-cap Russell 2000 Index as
well as the appropriate growth and value style indexes.
For more information on the Russell indexes and the Russell
indexes reconstitution, please visit the “Russell Reconstitution”
section on the FTSE Russell website.
About Venus Concept
Venus Concept is an innovative global medical aesthetic
technology leader with a broad product portfolio of minimally
invasive and non-invasive medical aesthetic and hair restoration
technologies and reach in over 60 countries and 29 direct markets.
Venus Concept focuses its product sales strategy on a
subscription-based business model in North America and in its
well-established direct global markets. Venus Concept’s product
portfolio consists of 10 aesthetic device platforms, including
Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva,
Venus Freeze Plus, and Venus Bliss. Venus Concept’s hair
restoration systems includes NeoGraft®, an automated hair
restoration system that facilitates the harvesting of follicles
during a FUE process and the ARTAS® and ARTAS iX® Robotic Hair
Restoration systems, which harvest follicular units directly from
the scalp and create recipient implant sites using proprietary
algorithms. Venus Concept has been backed by leading healthcare
industry growth equity investors including EW Healthcare Partners
(formerly Essex Woodlands), HealthQuest Capital, Longitude Capital
Management, and Aperture Venture Partners.
Cautionary Statement Regarding Forward-Looking
Statements
This communication contains “forward-looking” statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended (the “1933 Act”) and Section 21E of the Securities Exchange
Act of 1934, as amended (the “1934 Act”). Any statements contained
herein that are not of historical facts may be deemed to be
forward-looking statements. In some cases, you can identify these
statements by words such as such as “anticipates,” “believes,”
“plans,” “expects,” “projects,” “future,” “intends,” “may,”
“should,” “could,” “estimates,” “predicts,” “potential,”
“continue,” “guidance,” and other similar expressions that are
predictions of or indicate future events and future trends. These
forward-looking statements include, but are not limited to,
statements about the expected synergies and cost savings from our
merger with Venus Concept Ltd. and restructuring program; our
financial performance; the growth in demand for our systems and
other products; and general economic conditions, including the
global economic impact of COVID-19, involve risks and uncertainties
that may cause results to differ materially from those set forth in
the statements. These forward-looking statements are based on
current expectations, estimates, forecasts, and projections about
our business and the industry in which we operate and management's
beliefs and assumptions and are not guarantees of future
performance or developments and involve known and unknown risks,
uncertainties, and other factors that are in some cases beyond our
control. As a result, any or all of our forward-looking statements
in this communication may turn out to be inaccurate. Factors that
could materially affect our business operations and financial
performance and condition include, but are not limited to, those
risks and uncertainties described under Part I Item 1A—“Risk
Factors” in our most recent Annual Report on Form 10-K, Part II
Item 1A—“Risk Factors” in our Form 10-Q for the quarter ended March
31, 2020, and in other documents we may file with the SEC. You are
urged to consider these factors carefully in evaluating the
forward-looking statements and are cautioned not to place undue
reliance on the forward-looking statements. The forward-looking
statements are based on information available to us as of the date
of this communication. Unless required by law, we do not intend to
publicly update or revise any forward-looking statements to reflect
new information or future events or otherwise.
Investor Relations Contact:
Westwicke Partners on behalf of Venus Concept:
Mike Piccinino, CFA
VenusConceptIR@westwicke.com
Venus Concept (NASDAQ:VERO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Venus Concept (NASDAQ:VERO)
Historical Stock Chart
From Apr 2023 to Apr 2024